Navigation Links
Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched,,

Cyclosporine has revolutionised the transplantation scene in the last 20 years by helping with immunosuppresion. Novartis have so far had the patent for the drug and enjoyed the profits. The cost of the medicine is prohibitively expensive.However in the past few years other pharma companies have been allowed to manufacture the drug giving Novartis a competetion. The current tablet size are big and makes it uncomfortable to swallow.

The pharmaceutical company SangStat expects to launch significantly smaller cyclosporine capsule in Europe. The new cyclosporine capsule is significantly smaller than any cyclosporine capsule currently on the market.

"The replacement of our current capsule filing with this new capsule could offer SangStat a significant advantage over a 'me too' generic cyclosporine capsule in Europe" said Jean-Jacques Bienaimi, President and CEO. "This is a very positive development for SangStat. Compared to our current capsule product, we believe it has a stronger patent position and improved product characteristics."

SangStat competetors Novartis have a lawsuit filed against the company for SangCya oral solution.
'"/>




Page: 1

Related medicine news :

1. Novel biopsy technique for prostate cancer
2. Novel computer model for breast cancer
3. Novel research on liver cancer
4. Novel way to fight cancer
5. Novel test for bowel cancer
6. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
7. Novel Therapy for Chronic Problem
8. Blood Sugar Kept In Control By Novel Protein
9. Novel antibiotic dressing developed for improved wound healing
10. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
11. Novel drug holds promise for treatment of Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/24/2017)... ... August 24, 2017 , ... ... coding, billing and compliance. In the coming months, AudioEducator has lined up several ... all specialties. Delivered by nationally recognized experts, these healthcare training conferences are designed ...
(Date:8/23/2017)... ... August 23, 2017 , ... Loyale Healthcare today ... Mr. Smith joins other recent high-profile hires including Frank Massi, Chief Revenue Officer ... in 1993, helping physician practices and hospitals automate their clinical and financial processes ...
(Date:8/23/2017)... (PRWEB) , ... August 23, 2017 , ... The Stevie® Awards have announced the winners ... Awards , the world’s premier business awards competition. , Nominees in the 2017 IBAs were ... by a points system based on the total number of awards won in the IBAs ...
(Date:8/23/2017)... Indiana (PRWEB) , ... August 23, 2017 , ... ... Whitney Boling, MD , has returned home to Indiana, and is now seeing ... is a board-eligible ophthalmologist that specializes in the diagnosis and treatment of eye ...
(Date:8/23/2017)... Rosa, CA (PRWEB) , ... August 23, 2017 ... ... the Journal of the American Academy of Orthopaedic Surgeons , points out ... for patients suffering from pain or injury. According to the report, a wider ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... , Aug. 7, 2017 Insightin ... member acquisition, retention, and engagement, announced the selection ... Strategy and Product Development, effective as of February 2017. ... and technology implementation strategy for our clients. Wood ... experience in consulting and business analytics within the ...
(Date:8/7/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest independent specialty ... 2017.  All comparisons, unless otherwise noted, are to the quarter ... Second Quarter 2017 Highlights include: ... of 3.5% Total prescriptions dispensed of 220,000, ... versus 7.6% Gross profit per prescription ...
(Date:8/4/2017)...  Agragen, LLC, a Cincinnati ... nutraceutical, and aquacultural feed sectors, announces a significant ... candidates, AGR131.  This drug is designed to trap ... of patients suffering from inflammatory conditions such as ... Biological pharmaceuticals currently ...
Breaking Medicine Technology: